SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133655
Filing Date
2022-04-29
Accepted
2022-04-29 16:10:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d625895ddefa14a.htm DEFA14A 9851
2 GRAPHIC g625895g00a55.jpg GRAPHIC 331428
3 GRAPHIC g625895g00a56.jpg GRAPHIC 256140
  Complete submission text file 0001193125-22-133655.txt   820458
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38959 | Film No.: 22875415
SIC: 2834 Pharmaceutical Preparations